This counter will fly to China if the vaccine Generex is building succeeds.. right now, there is nothing, Even Generex shares have been trashed.. if u want to know when to hit this stock, monitor Generex shares. The minute it turns, you can depend on hitting this Bintai with success
As for Bintai is very good news for the company signing agreement for vaccine covid 19. As prices will goes up due to the company only have the agreement signing with the US. The prices goes up I don’t know why went down?? Normally is a good news how come is opposite??
Check out the performance of Healthcare counters today first. All are down. Yet, still expecting Bintai to fly how? For me, at least i see effort from the company, making things work somehow, not being the arrogant Pharmaniaga or Duopharma just waiting for vaccine to fall from the sky into their hands. Yes, i dont deny they do hv manybe the first preference from the government, and yes i have invested in them too, but at least this counter seems to work on something. Thats all I’m here for.
Almost HALF A BILLION DOLLARS IN NET LOSSES AS OF April 30, 2020.
To date, we have not been profitable and our accumulated net loss available to shareholders was $440,389,785 at April 30, 2020. Our losses have resulted principally from costs incurred in research and development, including clinical trials, and from general and administrative costs associated with our operations.
this is the further prove that thisGNBT does not had the ability to make the effective covid 19 vaccine......a lot of people here comment us to buy this bintai shit caused they had brought the share above rm0.70 else they are bintai worker....so,sell now.
The first split for GNBT took place on December 03, 2018. This was a 21 for 1 split, meaning for each share of GNBT owned pre-split, the shareholder now owned 21 shares. For example, a 1000 share position pre-split, became a 21000 share position following the split. GNBT's second split took place on October 31, 2019.
Bintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region
Upfront licensing fee of $2.5 million
100% funding for development, manufacturing and commercial registration of Ii-Key- SARS-CoV-2 prophylactic vaccine against COVID-19 in Malaysia
Milestone payments totaling $17.5 million upon approval by Malaysian Ministry of Health
Contracted royalty of $3 - $4.50 per dose of vaccine
Potential $150 million in GNBT revenues for vaccine sales in Malaysia
Potential to expand the partnership and development agreement in Australia, New Zealand, and the global HALAL markets
Idk why people are afraid and let those negative comments affect them, so far this company from my POV have involve with vaccines. Just wait for another good news.
so what go up?????then down again for sure....what is the support based? few signed useless MOU which does not worth any value???Ask yourself, do you believe this loss making GNBT which share valued at 20 US cents can produced an effective vaccine???so pathetic.........
@amithaba this is the further prove that thisGNBT does not had the ability to make the effective covid 19 vaccine......a lot of people here comment us to buy this bintai shit caused they had brought the share above rm0.70 else they are bintai worker....so,sell now.
Any vaccine research and development takes time and most of all money. GNBT if it has the technology, big names will likely prop up its stock prices. Imagine you own a drug company and you find that your competitor has capability to produce a drug sorely needed. Wont you just buy as many stocks from the market so that you get your toe, and eventually your feet into it. At least if you don't have the drug, this investment will still give you returns your shareholders will thank you for. But following GNBT's stock movement, this has not happened - otherwise the price wont be sliding so noticeably over the years. We are so far away - likely if they have anything, the scientific community in US would have shown their confidence in the stock price
Good idea, but what if they cant find a vaccine and Bintai exercise its first rights of refusal - they don't even have to apologise to shareholders because investments come with caveats. This is one of them.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bowman
2,596 posts
Posted by bowman > 2020-09-29 10:00 | Report Abuse
This counter will fly to China if the vaccine Generex is building succeeds.. right now, there is nothing, Even Generex shares have been trashed.. if u want to know when to hit this stock, monitor Generex shares. The minute it turns, you can depend on hitting this Bintai with success